Asia-Pacific Healthcare Outlook, 2018

The Year of Digital Innovation in Asia-Pacific

USD 4,950.00

* Required Fields

USD 4,950.00

PAY BY INVOICE

Be the first to review this product

The healthcare industry in Asia-Pacific (APAC) is expected to grow at 11.1% in 2018, making it one of the fastest growing regions in the world, as the global healthcare economy averages an annual growth rate of 4.8%. This positive growth is fuelled by increasing adoption of technology, innovative healthcare access programs, and delivery of care outside traditional hospital settings. Frost & Sullivan projects the APAC healthcare market to grow to $517 billion in 2018. For the region, healthcare challenges of access and affordability of new technology demand complex and innovative solutions from all industry stakeholders. Key industry issues that deserve attention include policy innovation, support for new busine

Table of Contents

1. Executive Summary
Key Findings—Asia-Pacific Healthcare Market Snapshot
2018 Predictions for the Asia-Pacific Healthcare Industry
Growth Opportunities in Asia-Pacific Healthcare Industry
Critical Success Factors
Scope and Segmentation
2. 2018 Global Healthcare Industry Snapshot
Global Healthcare Revenues by Sector in 2017 and 2018
3. 2018 Asia-Pacific Healthcare Industry Outlook and Predictions
Total APAC Revenue
Key APAC Countries to Watch
APAC will Face a Shortage of 3.4 Million Beds in 2018; This Number is Expected to Surge to 3.6 Million By 2022
Over 2 Million New People Across the Region will Buy Private Health Insurance in 2018
Fast-tracking innovative therapeutic products will reduce time-to-market to less than 6 months; China in the lead
Mental health will emerge as a key area of focus with a potential patient base of over 344 million in 2018
Biomarkers market in APAC will grow at 17.4% in 2018
Digital Platforms will Drive 20% Growth In The Clinical Trials Market, Hitting Revenue of Over $10 Billion
4. Notable Trends to Highlight for 2018 Across the Asia-Pacific Healthcare Industry
Six-digit treatment costs in oncology will compel companies to move toward outcome-based contracts
Personalization Combined with Consumer Empowerment will be the Key Ingredient for Prevention and Wellness
Government Focus on Price Caps on Medical Devices will Open Up New Possibilities in Some APAC Countries
Regional regulatory reforms and business transformations will propel further ASEAN harmonization
5. Growth Opportunities in the Asia-Pacific Healthcare Industry in 2018
Growth Opportunities in Asia-Pacific Healthcare Industry
Critical Success Factors
Top Trends in Pharmaceuticals & Biotechnology
Pharmaceutical & Biotechnology Trends
Pharmaceutical & Biotechnology Revenues
Pharmaceutical & Biotechnology Companies to Watch in 2018
6. Top Trends in In-Vitro Diagnostics
In-Vitro Diagnostics Trends
In-Vitro Diagnostics Revenues
In-Vitro Diagnostics Companies To Watch in 2018
7. Top Trends in Medical Technologies & Medical Imaging
Medical Technology Trends
Medical Imaging Trends
Medical Technologies Revenues
Medical Imaging Revenues
Medical Technology Companies to Watch in 2018
8. Top Trends in Digital Health
Digital Health Trends
Digital Health Revenues
Digital Health Companies To Watch in 2018
9. Top Trends in Healthcare Services
Healthcare Services Trends
Healthcare Services Market Size
Healthcare Services Companies To Watch in 2018
10. Asia-Pacific Country Snapshots
Spotlight Australia
Spotlight China
Spotlight India
Spotlight Indonesia
Spotlight Japan
Spotlight Malaysia
Spotlight New Zealand
Spotlight Philippines
Spotlight Singapore
Spotlight South Korea
Spotlight Taiwan
Spotlight Thailand
Spotlight Vietnam
11. Conclusion
Conclusions
Legal Disclaimer
12. Appendix I—Industry Regulatory Transitions, M&As and Partnerships
Major Regulatory Transitions Impacting Pharmaceuticals & Biotechnology
Key Industry Partnerships Impacting Pharmaceuticals & Biotechnology
Major Regulatory Transitions Impacting In-Vitro Diagnostics
Key Industry Partnerships Impacting In-Vitro Diagnostics
Major Regulatory Transitions Impacting Medical Technologies and Medical Imaging
Key Industry Partnerships Impacting Medical Technologies and Medical Imaging
Major Regulatory Transitions Impacting Digital Health
Key Industry Partnerships Impacting Digital Health
Major Regulatory Transitions Impacting Healthcare Services
Key Industry Partnerships Impacting Healthcare Services
13. Appendix
List of Exhibits


List of Figures & Charts

1. Total Healthcare Industry: Major Regulatory Transitions Impacting Pharmaceuticals & Biotechnology, APAC, 2017–2018
2. Total Healthcare Industry: M&As, JVs and Partnerships Impacting Pharmaceutical , APAC, 2017–2018
3. Total Healthcare Industry: Major Regulatory Transitions Impacting In-Vitro Diagnostics , APAC, 2017–2018
4. Total Healthcare Industry: M&As, JVs and Partnerships Impacting In-Vitro Diagnostics , APAC, 2017–2018
5. Total Healthcare Industry: Major Regulatory Transitions Impacting Medical Technologies, APAC, 2017–2018
6. Total Healthcare Industry: M&As, JVs and Partnerships Impacting Medical Technologies, APAC, 2017–2018
7. Total Healthcare Industry: Major Regulatory Transitions Impacting Digital Health, APAC, 2017–2018
8. Total Healthcare Industry: Major Regulatory Transitions Impacting Digital Health, APAC, 2017–2018
9. Total Healthcare Industry: M&As, JVs and Partnerships Impacting Digital Health, APAC, 2017–2018
10. Total Healthcare Industry: M&As, JVs and Partnerships Impacting Digital Health, APAC, 2017–2018
11. Total Healthcare Industry: Major Regulatory Transitions Impacting Digital Health, APAC, 2017–2018
12. Total Healthcare Industry: M&As, JVs and Partnerships Impacting Digital Health, APAC, 2017–2018


1. Total Healthcare Industry: Revenue Forecast, APAC, 2017 & 2018
2. Total Healthcare Industry: Revenue by Sector, Global, 2017 and 2018
3. Total Healthcare Industry: Percent Sales Breakdown by Region, Global, 2018
4. Total Healthcare Industry: Revenue Forecast, APAC, 2017 & 2018
5. Total Healthcare Industry: Industry Revenue by Segment, APAC, 2018
6. Total Healthcare Industry: Per Capita Healthcare Spending versus Private Health Insurance (PHI) Penetration, APAC, 2018
7. Total Healthcare Industry: 12-Month Prevalence of Mental Disorders, Select APAC Countries, 2017
8. Total Healthcare Industry: Biomarkers Revenue Forecast, APAC, 2017 and 2018
9. Total Healthcare Industry: Biosimilars Revenue Forecast, APAC, 2016–2018
10. Total Healthcare Industry: Total Regenerative Medicine Revenue Forecast, APAC, 2016–2018
11. Total Healthcare Industry: IVD Revenue Forecast, APAC, 2016–2018
12. IVD Market: Percent of Revenue by Segment, APAC, 2017
13. Total Healthcare Industry: Medical Technologies Revenue Forecast, APAC, 2016-2018
14. Total Healthcare Industry: Patient Monitoring Revenue Forecast, APAC, 2016-2018
15. Total Healthcare Industry: Medical Devices Revenue Forecast, APAC, 2016-2018
16. Total Healthcare Industry: Medical Imaging Revenue Forecast, APAC, 2016-2018
17. Total Healthcare Industry: Healthcare IT Revenue Forecast, APAC, 2016-2018
18. Total Healthcare Industry: Telehealth Revenue Forecast, APAC, 2016-2018
19. Total Healthcare Industry: Total Number of Hospitals Forecast, APAC, 2016-2018
20. Total Healthcare Industry: Existing Beds and Bed Demand Forecast, APAC, 2016-2018



Keyword1

Keyword2

Keyword3

Related Research

Release Date : 31-Jan-18

Region : Asia Pacific

Release Date : 23-Jan-18

Region : Asia Pacific

Release Date : 23-Jan-18

Region : Asia Pacific

Release Date : 10-Jan-18

Region : Asia Pacific

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.